|
1
|
Shah D, Aggarwal A, Bhatnagar A, Kiran R
and Wanchu A: Association between T lymphocyte sub-sets apoptosis
and peripheral blood mononuclear cells oxidative stress in systemic
lupus erythematosus. Free Radic Res. 45:559–567. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lusini L, Tripodi SA, Rossi R, et al:
Altered glutathione anti-oxidant metabolism during tumor
progression in human renal-cell carcinoma. Int J Cancer. 91:55–59.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ames BN, Shigenaga MK and Gold LS: DNA
lesions, inducible DNA repair, and cell division: three key factors
in mutagenesis and carcinogenesis. Environ Health Perspect.
101(Suppl 5): 35–44. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Moller P and Wallin H: Adduct formation,
mutagenesis and nucleotide excision repair of DNA damage produced
by reactive oxygen species and lipid peroxidation product. Mutat
Res. 410:271–290. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kongara S and Karantza V: The interplay
between autophagy and ROS in tumorigenesis. Front Oncol. 2:1712012.
View Article : Google Scholar
|
|
6
|
Kryston TB, Georgiev AB, Pissis P and
Georgakilas AG: Role of oxidative stress and DNA damage in human
carcinogenesis. Mutat Res. 711:193–201. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Eltzschig HK and Carmeliet P: Hypoxia and
inflammation. N Engl J Med. 364:656–665. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yeh CC, Hou MF, Wu SH, et al: A study of
glutathione status in the blood and tissues of patients with breast
cancer. Cell Biochem Funct. 24:555–559. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Suess E, Malessa S, Ungersböck K, et al:
Technetium-99m-d, l-hexaniethylpropyleneamine oxime (HMPAO) uptake
and glutathione content in brain tumors. J Nucl Med. 32:1675–1681.
1991.PubMed/NCBI
|
|
10
|
Grubben MJ, van den Braak CC, Nagengast FM
and Peters WH: Low colonic glutathione detoxification capacity in
patients at risk for colon cancer. Eur J Clin Invest. 36:188–192.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Peters WH, van Schaik A, Peters JH and van
Goor H: Oxidised- and total non-protein bound glutathione and
related thiols in gallbladder bile of patients with various
gastrointestinal disorders. BMC Gastroenterol. 7:72007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gupta A, Srivastava S, Prasad R, et al:
Oxidative stress in non-small cell lung cancer patients after
chemotherapy: association with treatment response. Respirology.
15:349–356. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Almadori G, Bussu F, Galli J, et al:
Salivary glutathione and uric acid levels in patients with head and
neck squamous cell carcinoma. Head Neck. 29:648–654. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kearns PR, Pieters R, Rottier MM, Pearson
AD and Hall AG: Raised blast glutathione levels are associated with
an increased risk of relapse in childhood acute lymphocytic
leukemia. Blood. 97:393–398. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Singh S, Khan AR and Gupta AK: Role of
glutathione in cancer pathophysiology and therapeutic
interventions. J Exp Ther Oncol. 9:303–316. 2012.PubMed/NCBI
|
|
16
|
Ziegler DM: Role of reversible
oxidation-reduction of enzyme thiols-disulfides in metabolic
regulation. Annu Rev Biochem. 54:305–329. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Huang CS, Chang LS, Anderson ME and
Meister A: Catalytic and regulatory properties of the heavy subunit
of rat kidney gamma-glutamylcysteine synthetase. J Biol Chem.
268:19675–19680. 1993.PubMed/NCBI
|
|
18
|
McConnachie LA, Mohar I, Hudson FN, et al:
Glutamate cysteine ligase modifier subunit deficiency and gender as
determinants of acetaminophen-induced hepatotoxicity in mice.
Toxicol Sci. 99:628–636. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Dalton TP, Dieter MZ, Yang Y, Shertzer HG
and Nebert DW: Knockout of the mouse glutamate cysteine ligase
catalytic subunit (Gclc) gene: embryonic lethal when homozygous,
and proposed model for moderate glutathione deficiency when
heterozygous. Biochem Biophys Res Commun. 279:324–329. 2000.
View Article : Google Scholar
|
|
20
|
Iida T, Kijima H, Urata Y, et al:
Hammerhead ribozyme against gamma-glutamylcysteine synthetase
sensitizes human colonic cancer cells to cisplatin by
down-regulating both the glutathione synthesis and the expression
of multidrug resistance proteins. Cancer Gene Ther. 8:803–814.
2001. View Article : Google Scholar
|
|
21
|
Eble JN, Sauter G, Epstein JI and
Sesterhenn IA: Pathology and Genetics of Tumours of the Urinary
System and Male Genital Organs. 1st edition. IARC Press; Lyon: pp.
12–43. 2004
|
|
22
|
Edge S, Byrd DR, Compton CC, Fritz AG,
Greene FL and Trotti A: AJCC Cancer Staging Manual. 7th edition.
Springer; New York, NY: pp. 103–115. 2010
|
|
23
|
Chen CN, Brown-Borg HM, Rakoczy SG,
Ferrington DA and Thompson LV: Aging impairs the expression of the
catalytic subunit of glutamate cysteine ligase in soleus muscle
under stress. J Gerontol A Biol Sci Med Sci. 65:129–137. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Franklin CC, Backos DS, Mohar I, White CC,
Forman HJ and Kavanagh TJ: Structure, function, and
post-translational regulation of the catalytic and modifier
subunits of glutamate cysteine ligase. Mol Aspects Med. 30:86–98.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Locigno R and Castronovo V: Reduced
glutathione system: role in cancer development, prevention and
treatment (review). Int J Oncol. 19:221–236. 2001.PubMed/NCBI
|
|
26
|
Kern JC and Kehrer JP: Free radicals and
apoptosis: relationships with glutathione, thioredoxin, and the BCL
family of proteins. Front Biosci. 10:1727–1738. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Montero AJ and Jassem J: Cellular redox
pathways as a therapeutic target in the treatment of cancer. Drugs.
71:1385–1396. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Solinas G, Marchesi F, Garlanda C,
Mantovani A and Allavena P: Inflammation-mediated promotion of
invasion and metastasis. Cancer Metastasis Rev. 29:243–248. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Maher P: The effects of stress and aging
on glutathione metabolism. Ageing Res Rev. 4:288–314. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yuan J, Zhang Z, Li L and Song W:
Resveratrol affects the expression of glutamate cysteine ligase in
the kidneys of aged rats. Exp Ther Med. 7:1762–1766.
2014.PubMed/NCBI
|
|
31
|
Estrela JM, Ortega A and Obrador E:
Glutathione in cancer biology and therapy. Crit Rev Clin Lab Sci.
43:143–181. 2006. View Article : Google Scholar
|
|
32
|
Backos DS, Franklin CC and Reigan P: The
role of glutathione in brain tumor drug resistance. Biochem
Pharmacol. 83:1005–1012. 2012. View Article : Google Scholar : PubMed/NCBI
|
